James Russell
Corporate Officer/Principal bei University of British Columbia
Profil
Mr. James Russell is Co-Founder at Sirius Genomics, Inc., a Professor at University of British Columbia, and an Associate Director-Intensive Care Unit at St. Paul's Hospital.
He received his doctorate degree from the University of Toronto.
Aktive Positionen von James Russell
| Unternehmen | Position | Beginn |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | 13.11.2009 |
St. Paul's Hospital
 St. Paul's Hospital Hospital/Nursing ManagementHealth Services St. Paul's Hospital operates a medical hospital. The private company is based in Hong Kong, Hong Kong. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von James Russell
| Unternehmen | Position | Ende |
|---|---|---|
Sirius Genomics, Inc.
 Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Gründer | - |
Ausbildung von James Russell
| University of Toronto | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
St. Paul's Hospital
St. Paul's Hospital Hospital/Nursing ManagementHealth Services St. Paul's Hospital operates a medical hospital. The private company is based in Hong Kong, Hong Kong. | Health Services |
